Table 1.
Characteristics of patients with FIGO stage IIIC1 (2018).
| Characteristics | No. (100%) |
|---|---|
| Total | 325 |
| Age (years old) | |
| Median | 50 |
| <30 | 5 (1.6%) |
| 30–39 | 26 (8.0%) |
| 40–49 | 131 (40.3%) |
| 50–59 | 118 (36.3%) |
| 60–69 | 39 (12%) |
| ≥70 | 6 (1.8%) |
| Histology | |
| Scc | 301 (92.6%) |
| non-Scc | 21 (6.5%) |
| unclear | 3 (0.9%) |
| Tumor size | |
| <4 cm | 80 (24.6%) |
| ≥4 cm | 240 (73.9%) |
| unclear | 5 (1.5%) |
| Parametrial infiltration | |
| yes | 265 (81.5%) |
| No | 60 (18.5%) |
| Invasion of pelvic wall | |
| yes | 60 (18.5%) |
| No | 265 (81.5%) |
| Invasion of the lower third of vagina | |
| Yes | 11 (3.4%) |
| No | 314 (96.6%) |
| Pelvic lymph node metastasis | |
| bilateral | 145 (44.6%) |
| unilateral | 135 (41.5%) |
| uncertainty | 45 (13.9%) |
| Common iliac lymph node metastasis | |
| yes | 49 (15.1%) |
| no | 231 (71.1%) |
| uncertainty | 45 (13.8%) |
| Number of PLNM | |
| ≥2 | 171 (52.6%) |
| <2 | 109 (33.5%) |
| uncertainty | 45 (13.9%) |
| CCT | |
| yes | 288 (88.6%) |
| no | 37 (11.4%) |
Abbreviations: FIGO = International Federation of Gynecology and Obstetrics, Scc = squamous cell carcinoma, CCT = concurrent chemotherapy, PLNM = pelvic lymph node metastasis.